Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value: $7.038B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 26,250,000 | $2.232B | 31.7% | $12.41 | — | Common | 452907108 |
| — | MIRATI THERAPEUTICS INC | 4,343,000 | $721M | 10.2% | $30.72 | — | Common | 60468T105 |
| — | HORIZON THERAPEUTICS PLC | 7,650,000 | $594M | 8.4% | $41.91 | — | Common | G46188101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 9,536,039 | $314M | 4.5% | $13.29 | +130.8% | Common | 462260100 |
| ASND | ASCENDIS PHARMA | 1,800,000 | $278M | 3.9% | $45.84 | — | Sponsored ADR | 04351P101 |
| — | MYOKARDIA INC | 1,885,000 | $257M | 3.7% | $62.23 | — | Common | 62857M105 |
| ARGX | ARGENX SE | 902,500 | $237M | 3.4% | $67.74 | — | Sponsored ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,675,000 | $235M | 3.3% | $108.54 | +40.0% | Common | 803607100 |
| — | ARENA PHARMACEUTICALS INC | 3,100,000 | $232M | 3.3% | $71.16 | — | Common | 040047607 |
| FOLD | AMICUS THERAPEUTICS INC | 10,850,000 | $153M | 2.2% | $10.45 | +39.4% | Common | 03152W109 |
| — | ACCELERON PHARMA INC | 1,350,000 | $152M | 2.2% | $95.79 | — | Common | 00434H108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,750,000 | $133M | 1.9% | $84.64 | +19.5% | Common | 09061G101 |
| — | MERSANA THERAPEUTICS INC | 6,800,000 | $127M | 1.8% | $23.19 | — | Common | 59045L106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 890,000 | $106M | 1.5% | $126.43 | -14.1% | Common | 558868105 |
| — | DECIPHERA PHARMACEUTICALS INC | 1,820,000 | $93.37M | 1.3% | $46.44 | — | Common | 24344T101 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 11,000,000 | $87.78M | 1.2% | $9.83 | — | Sponsored ADR | 00653A107 |
| — | KARYOPHARM THERAPEUTICS INC | 6,000,000 | $87.6M | 1.2% | $11.13 | — | Common | 48576U106 |
| — | CONSTELLATION PHARMACEUTICALS INC | 4,275,000 | $86.61M | 1.2% | $43.99 | — | Common | 210373106 |
| — | ADVERUM BIOTECHNOLOGIES INC | 8,000,000 | $82.4M | 1.2% | $11.14 | — | Common | 00773U108 |
| — | TRILLIUM THERAPEUTICS INC | 5,500,000 | $78.16M | 1.1% | $5.43 | — | Common | 89620X506 |
| KURA | KURA ONCOLOGY INC | 2,435,000 | $74.61M | 1.1% | $18.78 | +17.6% | Common | 50127T109 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $74.57M | 1.1% | $6.26 | — | Common | 23257D103 |
| QURE | UNIQURE NV | 1,750,000 | $64.45M | 0.9% | $53.43 | -23.3% | Common | N90064101 |
| PMVP | PMV PHARMACEUTICALS INC | 1,850,000 | $57.58M | 0.8% | $36.80 | 0.0% | Common | 69353Y103 |
| RLMD | RELMADA THERAPEUTICS INC | 1,500,000 | $56.43M | 0.8% | $40.59 | -4.8% | Common | 75955J402 |
| — | IVERIC BIO INC | 7,250,000 | $40.89M | 0.6% | $5.11 | — | Common | 46583P102 |
| — | ATHENEX INC | 3,265,000 | $39.51M | 0.6% | $18.13 | — | Common | 04685N103 |
| — | MARINUS PHARMACEUTICALS INC | 3,000,000 | $38.55M | 0.5% | $2.34 | — | Common | 56854Q101 |
| XENE | XENON PHARMACEUTICALS INC | 2,800,000 | $31M | 0.4% | $9.61 | +22.4% | Common | 98420N105 |
| CUE | CUE BIOPHARMA INC | 1,870,000 | $28.14M | 0.4% | $10.47 | +83.4% | Common | 22978P106 |
| ALT | ALTIMMUNE INC | 2,000,000 | $26.4M | 0.4% | $19.99 | 0.0% | Common | 02155H200 |
| — | AMARIN CORP PLC | 6,000,000 | $25.26M | 0.4% | $8.22 | — | Sponsored ADR | 023111206 |
| — | RETROPHIN INC | 1,325,000 | $24.46M | 0.3% | $20.01 | — | Common | 761299106 |
| RLAY | RELAY THERAPEUTICS INC | 500,000 | $21.3M | 0.3% | $38.13 | 0.0% | Common | 75943R102 |
| — | AVADEL PHARMACEUTICALS PLC | 4,200,000 | $21.17M | 0.3% | $7.95 | — | Sponsored ADR | 05337M104 |
| — | RAPT THERAPEUTICS INC | 575,000 | $18.52M | 0.3% | $32.20 | — | Common | 75382E109 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 602,500 | $18.21M | 0.3% | $30.25 | +0.6% | Common | 09203E105 |
| — | ZOGENIX INC | 875,000 | $15.69M | 0.2% | $34.80 | — | Common | 98978L204 |
| RNAM | AVIDITY BIOSCIENCES INC | 545,000 | $15.34M | 0.2% | $28.83 | +0.2% | Common | 05370A108 |
| — | THERAPEUTICS ACQUISITION CORP | 1,000,000 | $14.38M | 0.2% | $14.38 | — | Common | 88339T103 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $11.64M | 0.2% | $2.62 | 0.0% | Common | 372427401 |
| — | ITEOS THERAPEUTICS INC | 460,000 | $11.35M | 0.2% | $24.67 | — | Common | 46565G104 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,670,000 | $10.12M | 0.1% | $9.85 | -28.5% | Common | 31447P100 |
| — | BCTG ACQUISITION CORP | 800,000 | $8.672M | 0.1% | $10.84 | — | Common | 05492W103 |
| — | ALIMERA SCIENCES INC | 415,999 | $2.022M | 0.0% | $7.58 | — | Common | 016259202 |
| KYMR | KYMERA THERAPEUTICS INC | 49,400 | $1.596M | 0.0% | $30.53 | 0.0% | Common | 501575104 |